Precipio (PRPO) Competitors $19.50 -0.73 (-3.61%) Closing price 09/12/2025 03:59 PM EasternExtended Trading$19.42 -0.09 (-0.44%) As of 09/12/2025 04:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock PRPO vs. PRE, INTT, NAUT, OPXS, ODYS, OPTX, AATC, CLIR, DAIO, and MSAIShould you be buying Precipio stock or one of its competitors? The main competitors of Precipio include Prenetics Global (PRE), inTEST (INTT), Nautilus Biotechnology (NAUT), Optex Systems (OPXS), Odysight.ai (ODYS), Syntec Optics (OPTX), Autoscope Technologies (AATC), ClearSign Technologies (CLIR), Data I/O (DAIO), and MultiSensor AI (MSAI). These companies are all part of the "measuring and control equipment" industry. Precipio vs. Its Competitors Prenetics Global inTEST Nautilus Biotechnology Optex Systems Odysight.ai Syntec Optics Autoscope Technologies ClearSign Technologies Data I/O MultiSensor AI Precipio (NASDAQ:PRPO) and Prenetics Global (NASDAQ:PRE) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, media sentiment, earnings, analyst recommendations, valuation, risk, dividends and institutional ownership. Which has preferable earnings and valuation, PRPO or PRE? Precipio has higher earnings, but lower revenue than Prenetics Global. Precipio is trading at a lower price-to-earnings ratio than Prenetics Global, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPrecipio$18.53M1.70-$4.29M-$1.19-16.39Prenetics Global$30.62M4.27-$46.30M-$3.99-2.52 Do analysts recommend PRPO or PRE? Prenetics Global has a consensus target price of $9.00, indicating a potential downside of 10.63%. Given Prenetics Global's stronger consensus rating and higher possible upside, analysts clearly believe Prenetics Global is more favorable than Precipio.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Precipio 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Prenetics Global 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is PRPO or PRE more profitable? Precipio has a net margin of -8.48% compared to Prenetics Global's net margin of -115.91%. Precipio's return on equity of -15.00% beat Prenetics Global's return on equity.Company Net Margins Return on Equity Return on Assets Precipio-8.48% -15.00% -10.21% Prenetics Global -115.91%-28.07%-22.27% Does the media prefer PRPO or PRE? In the previous week, Prenetics Global had 9 more articles in the media than Precipio. MarketBeat recorded 11 mentions for Prenetics Global and 2 mentions for Precipio. Precipio's average media sentiment score of 1.45 beat Prenetics Global's score of 0.06 indicating that Precipio is being referred to more favorably in the media. Company Overall Sentiment Precipio Positive Prenetics Global Neutral Which has more volatility & risk, PRPO or PRE? Precipio has a beta of 1.09, meaning that its stock price is 9% more volatile than the S&P 500. Comparatively, Prenetics Global has a beta of 0.15, meaning that its stock price is 85% less volatile than the S&P 500. Do institutionals & insiders have more ownership in PRPO or PRE? 10.5% of Precipio shares are owned by institutional investors. Comparatively, 25.0% of Prenetics Global shares are owned by institutional investors. 16.9% of Precipio shares are owned by company insiders. Comparatively, 7.8% of Prenetics Global shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. SummaryPrecipio and Prenetics Global tied by winning 8 of the 16 factors compared between the two stocks. Get Precipio News Delivered to You Automatically Sign up to receive the latest news and ratings for PRPO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PRPO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PRPO vs. The Competition Export to ExcelMetricPrecipioMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$32.76M$2.15B$5.84B$10.14BDividend YieldN/AN/A5.68%4.60%P/E Ratio-16.3938.0975.4125.98Price / Sales1.709.95515.86180.60Price / CashN/A58.3137.5660.44Price / Book2.3911.6512.156.29Net Income-$4.29M-$63.67M$3.29B$271.07M7 Day Performance9.92%-0.25%0.74%3.87%1 Month Performance32.56%3.48%5.00%5.49%1 Year Performance213.50%133.43%62.55%25.86% Precipio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PRPOPrecipio0.9929 of 5 stars$19.50-3.6%N/A+213.5%$32.76M$18.53M-16.3960Short Interest ↓Gap UpPREPrenetics Global0.8237 of 5 stars$9.39+16.1%$9.00-4.2%+123.8%$105.05M$30.62M-2.351News CoverageEarnings ReportShort Interest ↑Gap UpHigh Trading VolumeINTTinTEST2.5003 of 5 stars$7.20-1.0%$12.00+66.7%+4.9%$90.72M$121.64M31.31320Positive NewsHigh Trading VolumeNAUTNautilus Biotechnology2.4948 of 5 stars$0.70+6.1%$2.13+203.1%-75.1%$83.49MN/A-1.35130News CoveragePositive NewsGap UpHigh Trading VolumeOPXSOptex Systems3.0015 of 5 stars$11.22-3.0%N/A+44.1%$79.99M$33.99M14.9680Short Interest ↓ODYSOdysight.ai1.8608 of 5 stars$4.03+6.6%$10.00+148.1%N/A$61.73M$3.96M-3.8040OPTXSyntec Optics0.4801 of 5 stars$1.75+16.7%N/A+22.6%$55.03M$29.44M0.003Upcoming EarningsShort Interest ↑High Trading VolumeAATCAutoscope Technologies2.4158 of 5 stars$7.25flatN/A-10.1%$39.80M$12.89M8.2440Positive NewsShort Interest ↓Gap DownCLIRClearSign Technologies2.8016 of 5 stars$0.59-0.5%$2.00+241.8%-29.8%$30.85M$3.60M-5.3210Positive NewsDAIOData I/O1.788 of 5 stars$3.20-0.3%$5.22+63.1%+37.6%$30.14M$22.73M-11.43100News CoverageGap DownMSAIMultiSensor AI3.8411 of 5 stars$0.69+6.3%$2.50+260.0%-65.3%$22.59M$5.59M0.0035Positive NewsGap Up Related Companies and Tools Related Companies Prenetics Global Alternatives inTEST Alternatives Nautilus Biotechnology Alternatives Optex Systems Alternatives Odysight.ai Alternatives Syntec Optics Alternatives Autoscope Technologies Alternatives ClearSign Technologies Alternatives Data I/O Alternatives MultiSensor AI Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PRPO) was last updated on 9/14/2025 by MarketBeat.com Staff From Our PartnersNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | SponsoredWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredApple’s falling behindApple just posted record-breaking results, yet its stock barely moved — because in today’s market, investors o...Porter & Company | Sponsored6-Figure Target for BTC by 2025The U.S. just announced it's putting GDP data directly onto Bitcoin and Ethereum blockchains. Could this spa...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Precipio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Precipio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
